Group 1 - The company Fulongma (SH 603686) announced that as of the disclosure date, the actual guarantee balance being performed by the company and its subsidiaries is approximately 222 million yuan, accounting for 6.64% of the company's most recent audited net assets, all of which are guarantees provided to subsidiaries within the consolidated financial statements and do not exceed the authorized guarantee limit of the company [1][1][1] - For the year 2024, the revenue composition of Fulongma is as follows: 75.88% from sanitation industry services, 21.4% from sanitation equipment manufacturing, 1.76% from other main businesses, and 0.96% from other operations [1][1][1] - As of the report, Fulongma's market capitalization is 10.1 billion yuan [1][1][1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion US dollars this year, indicating a hot secondary market in biomedicine, while the primary market is experiencing a fundraising slowdown [1]
福龙马:公司及控股子公司实际正在履行的担保余额约为2.22亿元